Cargando…
Network meta-analysis of 6 kinds of Chinese patent medicines combined with mifepristone in the treatment of uterine fibroids: A protocol for systematic review and network meta-analysis
BACKGROUND: Uterine fibroids are benign. They belong to the category of “abdominal mass” in traditional Chinese medicine, and pathogenesis is mainly caused by weakness of the body, qi stagnation, and blood stasis. Drug therapy is the preferred treatment of uterine fibroids in clinical practice, and...
Autores principales: | Bi, Chenhao, Qiao, Mingqi, Jia, Yuqi, Wang, Haijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542145/ https://www.ncbi.nlm.nih.gov/pubmed/34678886 http://dx.doi.org/10.1097/MD.0000000000027523 |
Ejemplares similares
-
Network meta-analysis of Chinese patent medicine adjuvant treatment of poststroke depression
por: Yu, Ying, et al.
Publicado: (2020) -
The efficacy and safety of Xuefu Zhuyu Decoction combined Mifepristone in the treatment of Uterine leiomyoma: A protocol systematic review and meta-analysis
por: Shi, Shasha, et al.
Publicado: (2021) -
Efficacy and safety of traditional Chinese herbal formula combined with western medicine for uterine fibroid: A protocol for systematic review and meta-analysis
por: Fu, Yu, et al.
Publicado: (2020) -
Effect and safety of oral Chinese patent medicine for heart failure: A protocol for systematic review and network meta-analysis
por: Guan, Hui, et al.
Publicado: (2020) -
Comparison of efficacy and safety of Chinese patent medicine in the treatment of postmenopausal osteoporosis: A protocol for systematic review and network meta-analysis
por: An, Hongqiang, et al.
Publicado: (2020)